News and Events
Mahmoud Al-Kofahi Joins ECP Faculty
Dr. Mahmoud Al-Kofahi has joined the ECP faculty as a tenure-track assistant professor specializing in pharmacometrics.
Dr. Al-Kofahi received his Ph.D. in Physiology in 2016 from the Department of Molecular and Cellular Physiology at the Louisiana State University Health Sciences Center. Since then, he has been a postdoctoral fellow at the University of Minnesota College of Pharmacy, working with Professor Richard Brundage. Dr. Al-Kofahi's research focus is in the areas of analysis and simulation of the pharmacokinetics-pharmacodynamics of biologics; circadian rhythms; and pharmacogenetic-based pharmacokinetic-pharmacodynamic models. Full bio
We are very excited to announce that Dr. R. Stephanie Huang, PhD, joined the the Department of Experimental and Clinical Pharmacology in the College of Pharmacy as a tenured associate professor in pharmacogenomics on August 31, 2017.
She is a board-certified clinical pharmacologist with extensive pharmacogenomic research in training in genetics, molecular and cell biology, clinical trials and high-throughput data analysis. Her laboratory’s main research focus is translational pharmacogenomics with a particular interest in the pharmacogenomics of anticancer agents. Read more
Pharmacogenomics: From Research to Implementation University of Minnesota
This year's Precision Medicine Conference had 300 attendees and the first 150 registrants were genotyped.
This conference presented current considerations and applications of genomics from national experts in pharmacogenomics who will discuss the status of precision medicine in the country, implementation into the clinical setting including incorporation of data into EMR and management of patients with these variants with an emphasis on psychiatry, cardiology and oncology applications.
Angela Birnbaum Receives NIH/NINDS Grant Support of $1.98 Million
MINNEAPOLIS / ST. PAUL (October 1, 2012) – Dr. Angela Birnbaum received support of $1.98 million from the NIH/National Institute of Neurological Disorders and Stroke for the project “Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs." Her investigation is part of a multi-clinical site proposal of approximately 20 sites nationally, which has a total grant award of $13.1 million. Her co-investigators are Dr. Rory Remmel (Department of Medicinal Chemistry) and Dr. Richard Brundage.
John Rotschafer to Receive ACCP's Prestigious Russell R. Miller Award
MINNEAPOLIS / ST. PAUL (September 20, 2012) – John Rotschafer, PharmD, FCCP, has been selected to receive this year’s prestigious Russell R. Miller Award from the American College of Clinical Pharmacy (ACCP). The award is given in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy.
Those who nominated Dr. Rotschafer praised his sustained record of publication, the impact of his manuscripts on therapeutic drug monitoring and dosing strategies, and his anti-infective research laboratory.
“Dr. Rotschafer’s research and publications shape much of what we know today about the pharmacokinetics, pharmacodynamics, and dosing of vancomycin, aminoglycosides, and fluoroquinolones,” said Dr. Elizabeth Hermsen. She noted that Rotschafer is one of few investigators to use an anaerobic chamber in in vitro pharmacodynamic modeling.
Dr. Keith Rodvold from the University of Illinois College of Pharmacy agreed that Dr. Rotschafer’s translational research was pioneering. “His in vitro model has allowed the evaluation of comparative pharmacokinetic-pharmacodynamic studies of anti-infective agents under aerobic and anaerobic conditions.”
Dr. Rotschafer will be presented with the award on October 21 in Hollywood, Florida, during the opening general session of ACCP’s annual meeting. The award is named for Russell R. Miller, who was the founding editor of ACCP’s journal, Pharmacotherapy.
Susan Marino Named Assistant Professor (Tenure Track) in Center for Clinical and Cognitive Neuropharmacology
MINNEAPOLIS / ST. PAUL (August 15, 2012) – Susan Marino, PhD, has joined the faculty of the Department of Experimental and Clinical Pharmacology as Assistant Professor (tenure track) for the Center for Clinical and Cognitive Neuropharmacology (C³N). In her new position, Dr. Marino will contribute her expertise in the area of neuropharmacology by teaching in both the professional and graduate programs of the College of Pharmacy.
She also holds the directorship of C3N. Established in 2010, the center advances one of ECP’s strategic goals: to build a concentration of scientists with a focus on neuroscience. Dr. Marino’s responsibilities include administration of C3N, external relations, strategic planning, and fundraising—and actively seeking the interdisciplinary collaborations that are essential to its mission.
“Dr. Marino has hit the ground running with a recent NIH grant, which will no doubt raise the profile of the ECP Department and the College of Pharmacy and show our leadership and innovation in the area of novel measures of predicting drug effects on cognition,” says Professor Robert Straka, head of the ECP department. “That our respected colleague Susan Marino will be taking on the challenge, along with colleagues from PCHS and other disciplines, is wonderful news for our department.”
Angela Birnbaum Named Interim Director of Graduate Studies for Fall 2012
MINNEAPOLIS / ST. PAUL (August 2, 2012) – Dr. Angela Birnbaum will serve as the Director of Graduate Studies (Interim) for the fall 2012 semester. Dr. Marnie Peterson will assume the role in the spring 2013 semester.
Robert Straka Appointed Department Head for ECP
MINNEAPOLIS / ST. PAUL (July 31, 2012) – Dr. Robert Straka has accepted the Department Head position for Experimental and Clinical Pharmacology, effective immediately. This appointment follows an extensive national search and collegiate interviewing of four candidates. Dr. Straka has served as interim department head since March.
Dr. Straka joined the College of Pharmacy faculty in 1987 and has previously served as associate department head and director of professional studies for ECP. His research is focused on optimizing the use of therapeutic agents used for the prevention and treatment of cardiovascular disease by investigating pharmacogenetic, pharmacokinetic, and pharmacodynamic sources of variability in response.